Glycyrrhizin has been shown to successfully prevent the occurrence of primary HCC in patients with HCV-related chronic liver disease by unknown mechanisms [168] . One of the principal roles of long-term administration of glycyrrhizin in decreasing the carcinogenesis rate seemed to be anti-inflammatory ones, which would retrieve an active carcinogenic process.